The clinical and epidemiological features of an outbreak of nosocomial Moraxella catarrhalis infection in a respiratory unit are described. Six isolates from five patients were shown to be indistinguishable by immunoblotting and restriction endonuclease analysis and different from 11 other, unrelated clinical strains. (Thorax 1993;48:91-92) Central Microbiological Laboratories
Moraxella (Branhamella) catarrhalis is a Gram negative, oxidase positive coccus, which has been increasingly recognised as a respiratory tract pathogen during the 1980s, especially in patients with underlying lung disease.' It most commonly causes exacerbations of chronic bronchitis but may also cause otitis media in children, conjunctivitis, or pneumonia.
This report describes the use of a combination of restriction endonuclease analysis (REA), immunoblotting, and SDS PAGE of whole cell proteins to examine six isolates of M catarrhalis from a cluster of infections among patients in a respiratory unit at the Northern General Hospital, Edinburgh.
Cases
The first case to be identified in this cluster of infections was in a 52 year old man with longstanding asthma. He was admitted to the respiratory unit with right sided chest pain and increasing dyspnoea. On admission his sputum was mucoid and culture yielded com- figure 1 . The duration of their stay in hospital before the onset of these symptoms ranged from six to 25 days. All the patients had started treatment with amoxycillin when they developed symptoms, in accordance with the unit's policy on antibiotics. Once the bacteriological results were available their treatment was changed to oral co-amoxiclav and thereafter their symptoms resolved rapidly. The discharge of one patient was delayed for four days as a consequence of this infection.
Because of the striking clustering of these cases we decided to look for more widespread carriage of M catarrhalis, but nose and throat swabs collected from symptomless patients were all negative. In view of the rapid response of the symptomatic patients to coamoxiclav, and the failure to find M catarrhalis during screening, no specific measures of infection control were instituted, and no further cases were identified. 
